Loading insider details...
Beta
Latest Form 4 (Feb 5, 2026): Grant/Award of 1,800,000 SABS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 5, 2026 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 1,800,000 | n/a |
| Aug 28, 2025 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 600,000 | n/a |
| Feb 23, 2024 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 140,000 | n/a |
| Mar 16, 2023 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 275,000 | n/a |
| Sep 15, 2022 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 274,875 | n/a |
| Mar 19, 2022 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 24,972 | n/a |
| Oct 27, 2021 | SAB Biotherapeutics, Inc. (SABS) | Grant/Award | 104,689 | n/a |